An international team of researchers experimenting with the function of the endocannabinoid system have shown how it can be manipulated to combat obesity with the help of a synthetic peptide.
Peptide with anti-obesity action is successfully tested in animal trial miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
A study conducted at the University of São Paulo in Brazil shows that the synthetic molecule Pep19 acts on the endocannabinoid system, which helps regulate and balance key metabolic functions, such as appetite, fat breakdown (lipolysis), and energy release.
A study published this month (May 2021) in the journal
Clinical Infectious Diseases suggests that people who have had dengue in the past are twice as likely to develop symptoms of Covid-19 if they are infected by the SARS-CoV-2 virus.
The findings of the study were based on an analysis of blood samples from 1,285 inhabitants of Mâncio Lima, a small town in the state of Acre, part of Brazil’s Amazon region.
Principal investigator and University of São Paulo’s Biomedical Sciences Institute (ICB-USP) professor Dr Marcelo Urbano Ferreira said: “Our results show that the populations most exposed to dengue, possibly owing to socio-demographic factors, are precisely those that are most at risk falling very sick if they’re infected by SARS-CoV-2.
Dengue May Double the Risk of Symptomatic COVID-19 medscape.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medscape.com Daily Mail and Mail on Sunday newspapers.